Steris (STE) Share-based Compensation (2018 - 2026)
Steris' (STE) quarterly Share-based Compensation came in at $12.9 million in Q1 2026, up 31.63% year-on-year from $9.8 million in Q1 2025, and down 17.83% quarter-over-quarter from $15.7 million in Q4 2025.
Steris (STE) Share-based Compensation (2018 - 2026) Analysis & Trends
Steris' Share-based Compensation history runs 9 years deep, the most recent figure standing at $12.9 million for Q1 2026.
- On a quarterly basis, Share-based Compensation rose 31.63% year-over-year to $12.9 million in Q1 2026; TTM through Mar 2026 was $61.7 million, a 7.49% increase from a year earlier, with the FY2026 full-year figure at $61.7 million, up 7.49% from the prior year.
- Share-based Compensation retreated to $12.9 million in Q1 2026 per STE's latest filing, from $15.7 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $21.2 million in Q3 2025 and bottomed at $8.9 million in Q1 2024.
- The 5-year median for Share-based Compensation is $11.6 million (2023), against an average of $13.2 million.
- Across the five-year window, Share-based Compensation plunged 66.3% in 2022 and jumped 79.39% in 2023, its largest moves.
- Year by year, Share-based Compensation stood at $9.3 million in 2022, then soared by 63.63% to $15.3 million in 2023, then grew by 0.05% to $15.3 million in 2024, then climbed by 2.61% to $15.7 million in 2025, then declined by 17.83% to $12.9 million in 2026.
- Per Business Quant, the three latest STE Share-based Compensation figures stand at $12.9 million (Q1 2026), $15.7 million (Q4 2025), and $21.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 12.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.90 Mn |
| Mar 31, 2026 | 12.90 Mn |
| Dec 31, 2025 | 15.70 Mn |
| Dec 31, 2025 | 15.70 Mn |
| Sep 30, 2025 | 21.20 Mn |
| Sep 30, 2025 | 21.20 Mn |
| Jun 30, 2025 | 11.90 Mn |
| Jun 30, 2025 | 11.90 Mn |
| Mar 31, 2025 | 9.80 Mn |
| Mar 31, 2025 | 9.80 Mn |
| Dec 31, 2024 | 15.30 Mn |
| Dec 31, 2024 | 15.30 Mn |
| Sep 30, 2024 | 20.80 Mn |
| Sep 30, 2024 | 20.80 Mn |
| Jun 30, 2024 | 11.50 Mn |
| Jun 30, 2024 | 11.50 Mn |
| Mar 31, 2024 | 8.91 Mn |
| Mar 31, 2024 | 8.91 Mn |
| Dec 31, 2023 | 15.29 Mn |
| Dec 31, 2023 | 15.29 Mn |